PennyStock101
Long

CLSD - Triple Bottom. Huge Analyst Prediction

NASDAQ:CLSD   CLEARSIDE BIOMEDICAL INC
Clearside Biomedical , Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Average Recommendation: OVERWEIGHT

Average Target Price: 5.50

SHORT INTEREST
2.26M 07/15/19

P/E Current
-0.48

P/E Ratio (with extraordinary items)
-0.72

Your Intro To Penny Stock Trading Success...

Sign Up for our 100% Free Email Newsletter:
http://www.PennyStock101.org

Text Message Alerts ---> text 'PS101' to 67076
(It's FREE, however Msg&Data rates may apply.)
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out